Skip to content
OpenCapital
Get started

Kinsale Capital Group KNSL Life Sciences — Gross written premiums

Other product segments

Commercial
$1.92B+5.3%
Commercial Property
$374.45M-17.9%
Excess Casualty
$277M+13.0%
General Casualty
$207.89M+22.9%
Small Business
$202.41M+3.5%
Construction
$147.6M-0.6%
Small Property
$102.41M+33.4%
Allied Health
$96.98M+16.8%
Entertainment
$70.05M+27.0%
Products Liability
$67.88M+1.3%
Personal
$59.79M+22.2%
Commercial Auto
$48.72M+39.0%
Energy
$46.1M+7.9%
Excess Professional
$41.45M+27.0%
High Value Homeowners
$36.06M+34.3%
Inland Marine
$33.53M+23.3%
Professional Liability Insurance
$33.09M-5.7%
Environmental
$31.56M+3.9%
Health Care
$25.82M+11.4%
Personal Insurance
$23.73M+7.4%
Management Liability
$18.58M-14.4%
Public Entity
$18.12M-9.6%
Agribusiness
$13.67M—
Aviation
$9.66M+12.4%
Agribusiness - Property
$8.67M—
Ocean Marine
$3.76M+2.9%
Product Recall
$2.69M+12.1%

Similar metrics at other companies

Globe Life logo
GLLife — Gross Premiums
$849M+2.8%
Chubb logo
CBSegment Life — Gross Premiums or Assessments
$2.12B+34.6%
Chubb logo
CBSegment Life — Net premiums written
$2.29B+33.1%
Aflac logo
AFLLife insurance — Gross premiums
$10.69B+2,103%
Axis Capital Holders logo
AXSInsurance — Gross premiums written
$1.98B+19.8%
MetLife logo
METLife insurance — Direct Premiums
$8.6B+27.8%

Other financials

Income statement

See full
Revenue$466.7M+10.2%
Net income$112.6M+26.1%
EPS (diluted)$4.88+27.4%

Balance sheet

See full
Cash & equivalents$223.3M+57.2%
Total debt$224.5M+21.9%
Total equity$2.0B+24.3%
Total assets$6.2B+19.2%

Cash flow

See full
Operating cash flow$248.9M+8.3%
CapEx$7.6M-37.8%
Free cash flow$241.3M+10.9%

Valuation

See full
Market cap$7.12B-30.2%
Enterprise value$7.12B-30.4%
P/E13.5×-11.7×
P/S3.7×-2.5×

Profitability

See full
Net margin27.5%+2.8pp
FCF margin52.9%-5.9pp

Returns & leverage

See full
Return on equity29.7%+0.3pp
Debt / equity0.1×0.0×

Where this comes from

Reported directly by Kinsale Capital Group in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenGross.

The official record: Kinsale Capital Group’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kinsale Capital Group's life sciences — gross written premiums.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kinsale Capital Group's life sciences — gross written premiums?
Kinsale Capital Group (KNSL) reported life sciences — gross written premiums of $8.82M in Q4 2025.
How has Kinsale Capital Group's life sciences — gross written premiums changed year-over-year?
Kinsale Capital Group's life sciences — gross written premiums decreased by 2.7% year-over-year, from $9.06M to $8.82M.
What is the long-term trend for Kinsale Capital Group's life sciences — gross written premiums?
Over 4 years (2021 to 2025), Kinsale Capital Group's life sciences — gross written premiums has grown at a -3.4% compound annual growth rate (CAGR), from $40.49M to $35.28M.
What does life sciences — gross written premiums mean?
This metric represents the total premiums generated from insurance policies underwritten within the life sciences sector, covering risks such as medical devices, pharmaceuticals, and biotechnology. It serves as a key indicator of the company's market penetration and underwriting appetite within this specialized, high-complexity industry vertical. Tracking this figure helps investors assess the growth trajectory and competitive positioning of the company's specialty insurance offerings relative to broader healthcare market trends.